Abstract:Background: COVID-19, caused by SARS-CoV-2 infection, has recently been announced as a pandemic all over the world. Remarkable achievements have been made in diagnosis, prevention and treatment of COVID-19 from clinical studies. However, animal models, particularly non-human primate models, are urgently needed for critical questions that could not be answered in clinical patients, evaluations of anti-viral drugs and vaccines. Methods: Two families of three species of non-human primates (NHP), old world monkeys (Macaca mulatta, Macaca fascicularis) and new world monkeys (Callithrix jacchus), were experimentally inoculated with SARS-CoV-2. Clinical signs were recorded. Samples were collected for analysis of viral shedding, viremia and evaluation of host responses to SARS-CoV-2 infection. Findings: Increased body temperature was observed in M. mulatta and M. fascicularis, but not C. jacchus post inoculation of SARS-CoV-2. All of M. mulatta and M. fascicularis showed chest radiographic abnormality. Viral genomes were detected in swab samples and blood from all 3 species of monkeys. Viral shedding from upper respiratory reached the peak between day 6 and day 8 post inoculation. Viruses were mainly detected in lung, weasand, bronchus and spleen of M. mulatta and M. fascicularis, but not C. jacchus. M. mulatta showed stronger cytokine responses to SARS-CoV-2 infection than M. fascicularis. Severe gross lesions and histopathological changes were observed mainly in lung and secondary lymphoid of SARS-CoV-2 infected M. mulatta and M. fascicularis. The susceptibility to SARS-CoV2 infection is M. mulatta > M. fascicularis > C. jacchus. Interpretations: We have established a NHP model for COVID-19, which recapitulates several important aspects of COVID-19 patients and could be used to evaluate anti-viral drugs and vaccines, and investigate viral pathogenesis.Funding Statement: This study was supported by 2020YFC0841100 and 2020YFC0846400. Declaration of Interests: None.Ethics Approval Statement: All animal procedures were approved by the Institutional Animal Care and Use Committee of Institute of Medical Biology, Chinese Academy of Medical Science (Ethics number: DWSP202002 001), and performed in the ABSL-4 facility of National Kunming High-level Biosafety Primate Research Center, Yunnan China.

SARS-CoV-2 susceptibility of cell lines and substrates commonly used in diagnosis and isolation of influenza and other viruses

Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses

Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species

Screening of Cell-Virus, Cell-Cell, Gene-Gene Cross-Talks among Kingdoms of Life at Single Cell Resolution

SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals

SARS‐CoV‐2 pseudovirus infectivity and expression of viral entry‐related factors ACE2, TMPRSS2, Kim‐1, and NRP‐1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig

Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1

Comparison of SARS-CoV-2 Infections Among Three Species of Non-Human Primates

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Susceptibility of swine cells and domestic pigs to SARS-CoV-2

SARS-CoV-2 immunity in animal models

Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

Single Cell Atlas for 11 Non-Model Mammals, Reptiles and Birds.

High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2

In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species

Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19

Highly Infectious SARS-CoV Pseudotyped Virus Reveals the Cell Tropism and Its Correlation with Receptor Expression.

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2